Athena Philis‐Tsimikas
About
Athena Philis‐Tsimikas is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and General Health Professions.
According to data from OpenAlex, Athena Philis‐Tsimikas has authored 116 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Endocrinology, Diabetes and Metabolism, 27 papers in Surgery and 27 papers in General Health Professions. Recurrent topics in Athena Philis‐Tsimikas's work include Diabetes Management and Research (83 papers), Diabetes Treatment and Management (53 papers) and Diabetes Management and Education (38 papers). Athena Philis‐Tsimikas is often cited by papers focused on Diabetes Management and Research (83 papers), Diabetes Treatment and Management (53 papers) and Diabetes Management and Education (38 papers). Athena Philis‐Tsimikas collaborates with scholars based in United States, Denmark and Canada. Athena Philis‐Tsimikas's co-authors include Chris Walker, Linda C. Gallo, Bernard Zinman, Chantal Mathieu, Addie L. Fortmann, Bertrand Cariou, Yehuda Handelsman, Helena W. Rodbard, Stephen R. Benoit and Ming Ji and has published in prestigious journals such as The Lancet, JAMA and SHILAP Revista de lepidopterología.
In The Last Decade
Athena Philis‐Tsimikas
104 papers receiving 3.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Athena Philis‐Tsimikas United States | 31 | 3.1k | 1.0k | 623 | 555 | 548 | 116 | 3.9k | ||
| Pablo Aschner Colombia | 33 | 3.0k 1.0× | 999 1.0× | 708 1.1× | 295 0.5× | 749 1.4× | 92 | 4.2k | ||
| Diana Isaacs United States | 20 | 2.3k 0.7× | 690 0.7× | 419 0.7× | 308 0.6× | 520 0.9× | 63 | 3.1k | ||
| Davida Kruger United States | 30 | 3.7k 1.2× | 1.8k 1.7× | 1.5k 2.5× | 348 0.6× | 305 0.6× | 114 | 4.6k | ||
| Billy S. Collins United States | 16 | 2.7k 0.9× | 856 0.8× | 497 0.8× | 181 0.3× | 758 1.4× | 35 | 3.9k | ||
| Irene Hramiak Canada | 27 | 1.5k 0.5× | 903 0.9× | 497 0.8× | 168 0.3× | 567 1.0× | 78 | 2.9k | ||
| Scott Kahan United States | 27 | 1.9k 0.6× | 915 0.9× | 408 0.7× | 353 0.6× | 452 0.8× | 67 | 3.9k | ||
| T. Lauritzen Denmark | 32 | 2.3k 0.7× | 500 0.5× | 457 0.7× | 263 0.5× | 394 0.7× | 81 | 3.4k | ||
| Mary Lou Perry United States | 14 | 1.7k 0.6× | 577 0.6× | 391 0.6× | 145 0.3× | 451 0.8× | 26 | 2.6k | ||
| Jane L. Chiang United States | 10 | 2.6k 0.8× | 1.3k 1.3× | 1.4k 2.3× | 181 0.3× | 432 0.8× | 15 | 4.0k | ||
| Belinda P. Childs United States | 17 | 3.4k 1.1× | 715 0.7× | 754 1.2× | 655 1.2× | 254 0.5× | 34 | 4.0k |
Countries citing papers authored by Athena Philis‐Tsimikas
Since
Specialization
Citations
This map shows the geographic impact of Athena Philis‐Tsimikas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Athena Philis‐Tsimikas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Athena Philis‐Tsimikas more than expected).
Fields of papers citing papers by Athena Philis‐Tsimikas
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Athena Philis‐Tsimikas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Athena Philis‐Tsimikas. The network helps show where Athena Philis‐Tsimikas may publish in the future.
Co-authorship network of co-authors of Athena Philis‐Tsimikas
This figure shows the co-authorship network connecting the top 25 collaborators of Athena Philis‐Tsimikas. A scholar is included among the top collaborators of Athena Philis‐Tsimikas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Athena Philis‐Tsimikas. Athena Philis‐Tsimikas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Philis‐Tsimikas, Athena, Jens Aberle, Harpreet S. Bajaj, et al.. (2025). Clinical Use of Once-Weekly Insulin Icodec: Translating Clinical Trial Data into Practical Guidance for Diabetes Management. Drugs. 85(10). 1253–1268.
2.
Klonoff, David C., David Ahn, David Kerr, et al.. (2025). Quantifying Environmental Waste From Diabetes Devices in the U.S.. Diabetes Care. 48(7). 1198–1203.
3.
Philis‐Tsimikas, Athena, Richard M. Bergenstal, Timothy S. Bailey, et al.. (2025). Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 2 diabetes currently treated with basal insulin (QWINT-3): a phase 3, randomised, non-inferiority trial. The Lancet. 405(10497). 2279–2289.
4.
Soriano, Emily C., et al.. (2024). Addressing emotional distress to improve outcomes in adults with type 1 diabetes: Protocol for ACT1VATE randomized controlled trial. Contemporary Clinical Trials. 146. 107687–107687.
5.
Philis‐Tsimikas, Athena, Addie L. Fortmann, Taylor L. Clark, et al.. (2024). Dulce Digital-Me: results of a randomized comparative trial of static versus adaptive digital interventions for Latine adults with diabetes. Annals of Behavioral Medicine. 59(1).
6.
Rhee, Connie M., Roma Gianchandani, David Kerr, et al.. (2024). Consensus Report on the Use of Continuous Glucose Monitoring in Chronic Kidney Disease and Diabetes. Journal of Diabetes Science and Technology. 19(1). 217–245.
7.
Polonsky, William H., Lisbeth Carstensen, Melanie J. Davies, et al.. (2024). Improved treatment satisfaction with once-weekly insulin icodec compared with once-daily basal insulin in individuals with type 2 diabetes: An analysis of patient-reported outcomes and participant interviews from ONWARDS 2 and 5 and a physician survey from ONWARDS 1. Diabetes Research and Clinical Practice. 217. 111885–111885.
8.
Philis‐Tsimikas, Athena, et al.. (2024). Are we Ready for Real-Time Continuous Glucose Monitoring in the Hospital Setting? Benefits, Challenges, and Practical Approaches for Implementation. Current Diabetes Reports. 24(10). 217–226.
9.
Fortmann, Addie L., Emily C. Soriano, Linda C. Gallo, et al.. (2024). Medical Assistant Health Coaching for Type 2 Diabetes in Primary Care: Results From a Pragmatic Cluster Randomized Controlled Trial. Diabetes Care. 47(7). 1171–1180.
10.
Bajaj, Harpreet S., Björg Ásbjörnsdóttir, Lisbeth Carstensen, et al.. (2024). Continuous Glucose Monitoring–Based Metrics and Hypoglycemia Duration in Insulin-Experienced Individuals With Long-standing Type 2 Diabetes Switched From a Daily Basal Insulin to Once-Weekly Insulin Icodec: Post Hoc Analysis of ONWARDS 2 and ONWARDS 4. Diabetes Care. 47(4). 729–738.
11.
Rose, Ludger, Takashi Kadowaki, Thomas R. Pieber, et al.. (2019). Efficacy and Safety of Fast-Acting Insulin Aspart in People with Type 1 Diabetes Using Carbohydrate Counting: A Post Hoc Analysis of Two Randomised Controlled Trials. Diabetes Therapy. 10(3). 1029–1041.
12.
Philis‐Tsimikas, Athena, Carol Wysham, Elise Hardy, Jenny Han, & Nayyar Iqbal. (2018). Efficacy and tolerability of exenatide once weekly over 7 years in patients with type 2 diabetes: An open-label extension of the DURATION-1 study. Journal of Diabetes and its Complications. 33(3). 223–230.
13.
Bailey, Timothy S., Anuj Bhargava, J. Hans DeVries, et al.. (2017). Day-to-day Variability of Fasting Self-Measured Blood Glucose (SMBG) Associates with Hypoglycemia Risk in Adults with Type 1 (T1D) or Type 2 Diabetes (T2D). Canadian Journal of Diabetes. 41(5). S57–S57.
14.
Philis‐Tsimikas, Athena, et al.. (2013). A New Option for Glycemic Control: Insulin Degludec, a New‐Generation Basal Insulin with an Ultralong Duration of Action. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 34(3). 291–302.
15.
Rodbard, Helena W., Bernard Zinman, Bertrand Cariou, et al.. (2012). Reduced nocturnal hypoglycaemia with insulin degludec as compared to insulin glargine: results of a 2-year randomised trial in type 2 diabetes. Diabetologia. 55.
16.
Fortmann, Addie L., Linda C. Gallo, & Athena Philis‐Tsimikas. (2011). Glycemic control among Latinos with type 2 diabetes: The role of social-environmental support resources.. Health Psychology. 30(3). 251–258.
17.
Fortmann, Addie L., Linda C. Gallo, Chris Walker, & Athena Philis‐Tsimikas. (2010). Support for disease management, depression, self-care, and clinical indicators among Hispanics with type 2 diabetes in San Diego County, United States of America. Revista Panamericana de Salud Pública. 28(3). 230–234.
18.
Philis‐Tsimikas, Athena, Quanwu Zhang, & Chris Walker. (2006). Glycemic Control With Insulin Glargine as Part of an Ethnically Diverse, Community-Based Diabetes Management Program. American Journal of Therapeutics. 13(6). 466–472.
19.
Benoit, Stephen R., et al.. (2004). PEER REVIEWED: Predictors of Dropouts From a San Diego Diabetes Program: A Case Control Study. Preventing Chronic Disease. 1(4).
20.
Philis‐Tsimikas, Athena, Sotirios Tsimikas, & Peter D. Reaven. (1996). A greek diet raises oleic acid levels and inhibits LDL oxidation. Journal of Investigative Medicine. 44(1).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Pablo Aschner Breakdown of academic impact, for papers by Diana Isaacs Breakdown of academic impact, for papers by Davida Kruger Breakdown of academic impact, for papers by Billy S. Collins Breakdown of academic impact, for papers by Irene Hramiak Breakdown of academic impact, for papers by Scott Kahan Breakdown of academic impact, for papers by T. Lauritzen Breakdown of academic impact, for papers by Mary Lou Perry Breakdown of academic impact, for papers by Jane L. Chiang Breakdown of academic impact, for papers by Belinda P. Childs